Free Shipping on Orders Above ₹399 | Shop Now & Save More
Telma-ACT Tablets
-13%
₹ 160.67 ₹ 184.68 -13%
SKU
Telma-ACT 40/5/6.25 Tablets contain Telmisartan IP 40 mg, Amlodipine Besylate IP equivalent to Amlodipine 5 mg, and Chlorthalidone IP 6.25 mg. This triple-combination prescription medicine is used for the management of hypertension (high blood pressure) in suitable patients requiring combination therapy. Its active ingredients work through complementary mechanisms to help relax blood vessels, reduce excess salt and fluid, and support effective blood pressure control. Use only as prescribed by a registered medical practitioner.
- Contains Telmisartan IP 40 mg
- Contains Amlodipine 5 mg
- Contains Chlorthalidone IP 6.25 mg
- Triple-combination therapy for hypertension management
- Combines an ARB, calcium channel blocker, and diuretic
- Helps relax blood vessels and support improved blood flow
- Chlorthalidone helps reduce excess salt and fluid from the body
- Prescription-only medicine for use under medical supervision
- Take exactly as prescribed by your physician.
- Swallow the tablet whole with water.
- Do not crush or chew unless specifically advised by your doctor.
- Take the medicine regularly at the same time each day as directed.
- Do not change the dose or discontinue treatment without consulting your physician.
- Monitor your blood pressure and complete any kidney function or electrolyte tests recommended by your doctor.
- Telmisartan IP: 40 mg
- Amlodipine Besylate IP: Equivalent to Amlodipine 5 mg
- Chlorthalidone IP: 6.25 mg
- Colours: Yellow Oxide of Iron & Titanium Dioxide IP
- Excipients: q.s.
- Dosage Form: Tablet
- Category: Prescription Medicine
- Manufacturer/Marketer: Glenmark Pharmaceuticals Ltd.
- Store below 30°C in a dry place, protected from light and moisture.
- Keep out of reach of children.
- Keep tablets in the original blister strip until ready to use.
- Use only under the supervision of a registered medical practitioner.
- Inform your doctor if you have kidney, liver, heart, or electrolyte-related problems.
- Inform your doctor immediately if pregnancy occurs. Telmisartan-containing medicines can cause fetal harm and require prompt medical review.
- This medicine may cause dizziness or lightheadedness in some people; avoid driving or operating machinery if affected.
- Regular monitoring of blood pressure, kidney function, and electrolytes may be required as advised by your physician.
- Do not use after the expiry date printed on the pack.
This is a prescription medicine. Information provided is for educational and product listing purposes only and does not replace professional medical advice. Always use this medicine under the supervision of a registered medical practitioner and follow the prescribed dosage, product label, and package insert carefully. Product composition, regulatory schedule classification, packaging, and other details should be verified from the current product pack as they may change with manufacturer or regulatory updates.
Customers albo bought
